Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Optical Coherence Tomography Features of Lattice Degeneration
Author Affiliations & Notes
  • Mehdi Emamverdi
    Doheny Eye Institute, Pasadena, California, United States
    Ophthalmology, University of California Los Angeles David Geffen School of Medicine, Los Angeles, California, United States
  • maryam ashrafkhorasani
    Doheny Eye Institute, Pasadena, California, United States
    Ophthalmology, University of California Los Angeles David Geffen School of Medicine, Los Angeles, California, United States
  • Abbas Habibi
    Doheny Eye Institute, Pasadena, California, United States
    Ophthalmology, University of California Los Angeles David Geffen School of Medicine, Los Angeles, California, United States
  • Pradeep Venkatesh
    Retina and Uvea Services, Dr.RP Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, Delhi, India
  • SriniVas R Sadda
    Doheny Eye Institute, Pasadena, California, United States
    Ophthalmology, University of California Los Angeles David Geffen School of Medicine, Los Angeles, California, United States
  • Footnotes
    Commercial Relationships   Mehdi Emamverdi None; maryam ashrafkhorasani None; Abbas Habibi None; Pradeep Venkatesh None; SriniVas Sadda 4DMT, Abbvie, Alexion, Allergan Inc., Alnylam Pharmaceuticals, Amgen Inc., Apellis Pharmaceuticals, Inc., Astellas, Bayer Healthcare Pharmaceuticals, Biogen MA Inc., Boehringer Ingelheim, Carl Zeiss Meditec, Catalyst Pharmaceuticals Inc., Centervue Inc., GENENTECH, Gyroscope Therapeutics, Heidelberg Engineering, Hoffman La Roche, Ltd., Iveric Bio, Janssen Pharmaceuticals Inc., Nanoscope, Notal Vision Inc., Novartis Pharma AG, Optos Inc., Oxurion/Thrombogenics, Oyster Point Pharma, Regeneron Pharmaceuticals Inc., Samsung Bioepis, Topcon Medical Systems Inc, Code C (Consultant/Contractor), Carl Zeiss Meditec, Heidelberg Engineering, Optos Inc., Nidek, Topcon, Centervue, Code F (Financial Support), Carl Zeiss Meditec, Heidelberg Engineering, Nidek Incorporated, Novartis Pharma AG, Topcon Medical Systems Inc, Code R (Recipient)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 5514. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Mehdi Emamverdi, maryam ashrafkhorasani, Abbas Habibi, Pradeep Venkatesh, SriniVas R Sadda; Optical Coherence Tomography Features of Lattice Degeneration. Invest. Ophthalmol. Vis. Sci. 2024;65(7):5514.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Lattice degeneration is a common peripheral retinal degenerative abnormality that is clinically significant as it increases the risk for retinal breaks and rhegmatogenous retinal detachment(RD). We utilize far peripheral swept-source optical coherence tomography(SS-OCT) imaging to evaluate the morphologic characteristics of lattice degeneration.

Methods : In this retrospective, observational case study, we included eyes with lattice degeneration with OCT imaging. All images were obtained using the Optos Silverstone SS-OCT(Optos PLC; Dunfermline, UK). An ultra-widefield(UWF; 200°) pseudocolor image was obtained to identify the lattice degenerative lesion(s) and a 6x6mm OCT volume was obtained over the lesion(s). For this analysis, only a single lesion (in case multiple lesions were present in the eye) was included. For eyes with more than one lesion, the most clearly visible lesion with the highest quality OCT images was selected. The OCT B-scans of the lesion were evaluated for the presence of several features including: vitreoretinal adhesion at the border, retinal thickness (within the lattice lesion relative to the adjacent retina), choroidal thickness (below lattice lesion), intraretinal hyperreflective foci(IHRF), retinal cystoid spaces, retinal (atrophic) hole, subretinal fluid, retinal schisis, and increased retinal reflectivity.

Results : A total of 53 eyes(39 patients) were included in this study. 53 eyes (100 %) showed evidence of retinal thinning within the lattice lesion. 51 eyes(96.2%) demonstrated vitreoretinal adhesion at the border of the lesion. 43 eyes(81.1%) showed choroidal thinning(relative to the adjacent choroid) and 5 eyes(9.4%) showed a thicker choroid below the lattice lesions. Other findings include Intraretinal hyperreflective foci in 29 eyes(54.7%), an increase of retinal reflectivity in lattice lesions in 24 eyes(45.3%), intraretinal cystoid spaces in 13 eyes(24.5%), retinal holes in 9 eyes(17%), subretinal fluid in 6 eyes(11.3%) and retinal schisis in 2 eyes(3.8%).

Conclusions : In this study using peripheral OCT, we demonstrated that lattice degeneration lesions can be associated with alterations of the retina, vitreous, and choroid. While retinal thinning and vitreoretinal adhesion were nearly universally present, choroidal thinning, hyperreflective foci, and increased retinal reflectivity were also frequently present. These findings may provide new insights into the pathogenesis of these lesions.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×